--- title: "TANDEM DIABETES CARE INC (TNDM) stock and investor profile" url: "https://aibio.space/companies/tandem-diabetes-care/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "TANDEM DIABETES CARE INC (NASDAQ: TNDM), United States. Listing facts, related biotech companies and news on aibio.space." --- TNDM TANDEM DIABETES CARE INC NASDAQ · United States # TANDEM DIABETES CARE INC (TNDM) news TANDEM DIABETES CARE INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TNDM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest TANDEM DIABETES CARE INC news We have not published a story on TANDEM DIABETES CARE INC yet. When there is news, it will appear here. ## TANDEM DIABETES CARE INC at a glance - **Ticker**: TNDM - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $456.0 million ### Related companies - [DEXCOM INC](https://aibio.space/companies/dexcom/) NASDAQ: DXCM - [TREACE MEDICAL CONCEPTS, INC.](https://aibio.space/companies/treace-medical-concepts/) NASDAQ: TMCI - [ENDONOVO THERAPEUTICS, INC.](https://aibio.space/companies/endonovo-therapeutics/) OTC: ENDV - [ILLUMINA, INC.](https://aibio.space/companies/illumina/) NASDAQ: ILMN - [TFA Therapeutics](https://aibio.space/companies/tfa-therapeutics/) OTC: RAJAF - [United Health Products](https://aibio.space/companies/united-health-products/) OTC: UEEC - [Fulgent Genetics](https://aibio.space/companies/fulgent-genetics/) NASDAQ: FLGT - [INTEGRA LIFESCIENCES HOLDINGS CORP](https://aibio.space/companies/integra-lifesciences/) NASDAQ: IART ### Also on NASDAQ - [Scholar Rock Holding](https://aibio.space/companies/scholar-rock/) SRRK - [CapsoVision](https://aibio.space/companies/capsovision/) CV - [Palvella Therapeutics](https://aibio.space/companies/palvella-therapeutics/) PVLA - [Bone Biologics](https://aibio.space/companies/bone-biologics/) BBLG - [Decoy Therapeutics](https://aibio.space/companies/decoy-therapeutics/) DCOY - [IMMUCELL CORP /DE/](https://aibio.space/companies/immucell-de/) ICCC ## TANDEM DIABETES CARE INC annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$1.01 billion](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/) | [$940.2 million](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/) | | Net income (loss) | [-$204.7 million](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/) | [-$96.0 million](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/) | | Cash from operations | [-$9.7 million](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/) | [$24.2 million](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/) | | Cash and equivalents | [$90.6 million](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000125/) | [$69.2 million](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/) | | Short-term investments | [$202.0 million](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000125/) | [$369.1 million](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $62.8 million, plus short-term investments of $393.2 million, $456.0 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about TANDEM DIABETES CARE INC What is the ticker symbol of TANDEM DIABETES CARE INC? TANDEM DIABETES CARE INC trades under the ticker TNDM on NASDAQ. Where is TANDEM DIABETES CARE INC listed? TANDEM DIABETES CARE INC is listed on NASDAQ. Which country or territory is TANDEM DIABETES CARE INC listed under? Our directory records TANDEM DIABETES CARE INC under United States. Does aibio.space cover TANDEM DIABETES CARE INC? aibio.space lists TANDEM DIABETES CARE INC among 2,820 public biotech companies and publishes its news here as stories appear. What was TANDEM DIABETES CARE INC's revenue last year? $1.01 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is TANDEM DIABETES CARE INC profitable? TANDEM DIABETES CARE INC reported a net loss of $204.7 million for the fiscal year ended Dec 31, 2025, and used $9.7 million of cash in operations, per its annual report to the SEC. How much cash does TANDEM DIABETES CARE INC have? $456.0 million in cash and short-term investments at Jun 30, 2026, per its 10-Q. ## Investor discussion: TANDEM DIABETES CARE INC Members talk about TANDEM DIABETES CARE INC (TNDM). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:TNDM on TradingView](https://www.tradingview.com/symbols/NASDAQ-TNDM/). ## Listing details TANDEM DIABETES CARE INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TNDM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: TANDEM DIABETES CARE INC - **Ticker**: TNDM - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/tandem-diabetes-care/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "TANDEM DIABETES CARE INC (TNDM) stock and investor profile", 2026-10-31, https://aibio.space/companies/tandem-diabetes-care/